In Re Lipitor (Atorvastatin Calcium) Marketing Sales Practices and Products Liability Litigation (No II) MDL 2502

  1. November 08, 2016

    SC Judge Says 70 Lipitor Suits Should Go Back To Calif.

    The South Carolina federal judge overseeing multidistrict litigation over claims that Pfizer's Lipitor causes Type 2 diabetes on Monday said that roughly 70 suits should be sent back to California, finding that the pharmaceutical giant can't show that claims against a distributor have no hope of survival.

  2. November 03, 2016

    Lipitor Users Say Diabetes Claims Belong In Calif. Court

    Consumers on Wednesday asked a South Carolina judge to send their suits in multidistrict litigation over claims that Pfizer's Lipitor causes Type 2 diabetes to state or federal court in California, saying their claims against a distributor based in that state aren't preempted.

  3. November 02, 2016

    Lipitor Diabetes Suits Against Pharmacy Booted From MDL

    The South Carolina federal judge overseeing multidistrict litigation over claims that Pfizer's cholesterol drug Lipitor causes Type 2 diabetes sent two suits back to Michigan state court Tuesday, saying there is a "glimmer of hope" that some claims against a pharmacy could survive there.

  4. August 19, 2016

    Lipitor Buyers Say Claims Can't Be Axed Before Discovery

    Consumers in multidistrict litigation over claims that Pfizer's cholesterol drug Lipitor causes Type 2 diabetes told a South Carolina federal judge on Thursday that their claims shouldn't be nixed before they've had a chance to conduct discovery specific to their cases.

  5. July 25, 2016

    Consumers Fight Pfizer Bid To Escape Lipitor MDL

    Consumers struck back against Pfizer's bid to escape multidistrict litigation over claims that its cholesterol drug Lipitor causes Type 2 diabetes, telling a South Carolina federal court the consumers need no expert evidence to show the drug causes the disease.

  6. June 24, 2016

    Pfizer Seeks Escape From Lipitor Diabetes MDL Claims

    Looking to end claims that its cholesterol drug Lipitor causes Type 2 diabetes, Pfizer on Friday told a South Carolina federal judge overseeing the multidistrict litigation that all the consumers lack admissible expert testimony proving that the drug specifically caused the disease.

  7. May 10, 2016

    Pfizer Ducks State Law Label Claims In Lipitor MDL

    The South Carolina federal judge overseeing multidistrict litigation over claims that Pfizer's cholesterol drug Lipitor can cause diabetes tossed state law claims that the drugmaker had to include different statements on the drug's label about its efficacy in women.

  8. April 25, 2016

    Pfizer Accuses Lipitor Users Of Forum-Shopping In MDL

    Pfizer on Friday told a South Carolina federal judge that hundreds of California consumers trying to move their suits over the company's cholesterol drug Lipitor, which they claim can cause diabetes, from multidistrict litigation to state court are trying to forum-shop after an adverse ruling in federal court.

  9. August 07, 2015

    Product Liability Cases To Watch In The Second Half Of 2015

    Attorneys following the General Motors ignition switch defect litigation are particularly interested in the scope of Jenner & Block chairman Anton Valukas' upcoming deposition, while trial lawyers will pay close attention to the first bellwether case in the Lipitor multidistrict litigation as well as the performance of the Zoloft plaintiffs' key expert witness. Here, Law360 eyes the cases product liability attorneys will be tracking in the second half of the year.